• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

革兰氏阴性微生物群失调通过激活食管鳞状细胞癌中的CCL3/CCL5-CCR1-MAPK-PD-L1途径促进肿瘤进展和免疫逃逸。

Gram-Negative Microflora Dysbiosis Facilitates Tumor Progression and Immune Evasion by Activating the CCL3/CCL5-CCR1-MAPK-PD-L1 Pathway in Esophageal Squamous Cell Carcinoma.

作者信息

Yang Huiqin, Cai Jiahao, Huang Xiaolong, Zhan Cheng, Lu Chunlai, Gu Jie, Ma Teng, Zhang Hongyu, Cheng Tao, Xu Fengkai, Ge Di

机构信息

Zhongshan Hospital, Fudan University, Shanghai, China.

出版信息

Mol Cancer Res. 2025 Jan 2;23(1):71-85. doi: 10.1158/1541-7786.MCR-24-0451.

DOI:10.1158/1541-7786.MCR-24-0451
PMID:39352512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11694060/
Abstract

Gram-negative (G-) microflora dysbiosis occurs in multiple digestive tumors and is found to be the dominant microflora in the esophageal squamous cell carcinoma (ESCC) microenvironment. The continuous stimulation of G- bacterium metabolites may cause tumorigenesis and reshape the microimmune environment in ESCC. However, the mechanism of G- bacilli causing immune evasion in ESCC remains underexplored. We identified CC chemokine receptor 1 (CCR1) as a tumor-indicating gene in ESCC. Interestingly, expression levels of CCR1 and PD-L1 were mutually upregulated after G- bacilli metabolite lipopolysaccharide stimulation. First, we found that CCR1 high expression levels were associated with poor overall survival in ESCC. Importantly, we found that high levels of CCR1 expression upregulated PD-L1 expression by activating MAPK phosphorylation in ESCC and induced tumor malignant behavior. Finally, we found that T-cell exhaustion and cytotoxicity suppression were associated with CCR1 expression in ESCC, which were decreased after CCR1 inhibiting. Our work identifies CCR1 as a potential immune check point regulator of PD-L1 and may cause T-cell exhaustion and cytotoxicity suppression in ESCC microenvironment and highlights the potential value of CCR1 as a therapeutic target of immunotherapy. Implications: The esophageal microbial environment and its metabolites significantly affect the outcome of immunotherapy for ESCC.

摘要

革兰氏阴性(G-)微生物群失调发生在多种消化系统肿瘤中,并且被发现是食管鳞状细胞癌(ESCC)微环境中的主要微生物群。G-细菌代谢产物的持续刺激可能导致肿瘤发生并重塑ESCC中的微免疫环境。然而,G-杆菌在ESCC中导致免疫逃逸的机制仍未得到充分探索。我们确定CC趋化因子受体1(CCR1)为ESCC中的一个肿瘤指示基因。有趣的是,在G-杆菌代谢产物脂多糖刺激后,CCR1和PD-L1的表达水平相互上调。首先,我们发现CCR1高表达水平与ESCC患者较差的总生存期相关。重要的是,我们发现高水平的CCR1表达通过激活ESCC中的MAPK磷酸化上调PD-L1表达并诱导肿瘤恶性行为。最后,我们发现T细胞耗竭和细胞毒性抑制与ESCC中的CCR1表达相关,在CCR1抑制后这些情况有所减轻。我们的研究确定CCR1为PD-L1的潜在免疫检查点调节剂,可能在ESCC微环境中导致T细胞耗竭和细胞毒性抑制,并突出了CCR1作为免疫治疗靶点的潜在价值。启示:食管微生物环境及其代谢产物显著影响ESCC免疫治疗的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0df4/11694060/71e4893a5d51/mcr-24-0451_f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0df4/11694060/b5ce4cd45661/mcr-24-0451_f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0df4/11694060/06704c2a8d13/mcr-24-0451_f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0df4/11694060/b2424f8aa901/mcr-24-0451_f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0df4/11694060/807672a8ab8f/mcr-24-0451_f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0df4/11694060/cea6238590a4/mcr-24-0451_f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0df4/11694060/e570be2a06ff/mcr-24-0451_f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0df4/11694060/71e4893a5d51/mcr-24-0451_f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0df4/11694060/b5ce4cd45661/mcr-24-0451_f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0df4/11694060/06704c2a8d13/mcr-24-0451_f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0df4/11694060/b2424f8aa901/mcr-24-0451_f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0df4/11694060/807672a8ab8f/mcr-24-0451_f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0df4/11694060/cea6238590a4/mcr-24-0451_f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0df4/11694060/e570be2a06ff/mcr-24-0451_f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0df4/11694060/71e4893a5d51/mcr-24-0451_f7.jpg

相似文献

1
Gram-Negative Microflora Dysbiosis Facilitates Tumor Progression and Immune Evasion by Activating the CCL3/CCL5-CCR1-MAPK-PD-L1 Pathway in Esophageal Squamous Cell Carcinoma.革兰氏阴性微生物群失调通过激活食管鳞状细胞癌中的CCL3/CCL5-CCR1-MAPK-PD-L1途径促进肿瘤进展和免疫逃逸。
Mol Cancer Res. 2025 Jan 2;23(1):71-85. doi: 10.1158/1541-7786.MCR-24-0451.
2
CircNF1 modulates the progression and immune evasion of esophageal squamous cell carcinoma through dual regulation of PD-L1.环状核纤层蛋白1(CircNF1)通过对程序性死亡受体配体1(PD-L1)的双重调控来调节食管鳞状细胞癌的进展和免疫逃逸。
Cell Mol Biol Lett. 2025 Mar 29;30(1):37. doi: 10.1186/s11658-025-00712-y.
3
Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.食管鳞癌中 PD-L1 表达、免疫浸润与 m6A RNA 甲基化调控因子的综合分析
Front Immunol. 2021 May 12;12:669750. doi: 10.3389/fimmu.2021.669750. eCollection 2021.
4
CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.CCL2-CCR2 轴通过 PD-1 信号招募肿瘤相关巨噬细胞诱导免疫逃逸在食管癌变中。
Mol Cancer. 2020 Feb 27;19(1):41. doi: 10.1186/s12943-020-01165-x.
5
Prognostic value of tumor-infiltrating lymphocytes and PD-L1 expression in esophageal squamous cell carcinoma.肿瘤浸润淋巴细胞和 PD-L1 表达在食管鳞状细胞癌中的预后价值。
Cancer Med. 2024 Sep;13(17):e70179. doi: 10.1002/cam4.70179.
6
Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.肿瘤浸润免疫细胞及PD-L1表达在食管鳞状细胞癌中的预后意义
Oncotarget. 2017 May 2;8(18):30175-30189. doi: 10.18632/oncotarget.15621.
7
Correlation of PD-L1 expression with CD8+ T cells and oxidative stress-related molecules NRF2 and NQO1 in esophageal squamous cell carcinoma.PD-L1 表达与食管鳞状细胞癌中 CD8+ T 细胞及氧化应激相关分子 NRF2 和 NQO1 的相关性。
J Pathol Clin Res. 2024 Jul;10(4):e12390. doi: 10.1002/2056-4538.12390.
8
Impacts of combining PD-L1 inhibitor and radiotherapy on the tumour immune microenvironment in a mouse model of esophageal squamous cell carcinoma.程序性死亡受体 1 配体(PD-L1)抑制剂与放疗联合应用对食管鳞状细胞癌小鼠模型肿瘤免疫微环境的影响
BMC Cancer. 2025 Mar 14;25(1):474. doi: 10.1186/s12885-025-13801-0.
9
Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.上皮内CD3+ T淋巴细胞增多以及肿瘤细胞上程序性死亡受体配体1(PD-L1)高表达与食管鳞状细胞癌的良好预后相关,并可进行预后免疫原性亚组划分。
Oncotarget. 2017 Jul 18;8(29):46756-46768. doi: 10.18632/oncotarget.18606.
10
Vimentin, inversely correlating with infiltration of CD8 + T lymphocytes, promotes nuclear translocation of PD-L1 in esophageal squamous cell carcinoma.波形蛋白与 CD8+T 淋巴细胞浸润呈负相关,促进食管鳞癌 PD-L1 的核转位。
Biochim Biophys Acta Mol Cell Res. 2024 Oct;1871(7):119781. doi: 10.1016/j.bbamcr.2024.119781. Epub 2024 Jun 18.

本文引用的文献

1
Intracellular Fusobacterium nucleatum infection attenuates antitumor immunity in esophageal squamous cell carcinoma.核梭杆菌感染细胞可减弱食管鳞状细胞癌中的抗肿瘤免疫。
Nat Commun. 2023 Sep 18;14(1):5788. doi: 10.1038/s41467-023-40987-3.
2
Intratumoral Bacteria as Mediators of Cancer Immunotherapy Response.肿瘤内细菌作为癌症免疫疗法反应的介导物。
Cancer Res. 2023 Sep 15;83(18):2985-2986. doi: 10.1158/0008-5472.CAN-23-1857.
3
Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial.
在局部晚期可切除食管鳞癌中的新辅助 adebrelimab:1b 期试验。
Nat Med. 2023 Aug;29(8):2068-2078. doi: 10.1038/s41591-023-02469-3. Epub 2023 Jul 24.
4
Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment.肿瘤 PD-L1 与髓系 PD-1 结合,抑制 I 型干扰素,从而损害细胞毒性 T 淋巴细胞的募集。
Cancer Cell. 2023 Mar 13;41(3):620-636.e9. doi: 10.1016/j.ccell.2023.02.005.
5
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy.p38MAPKα 基质重编程使转移性乳腺癌对免疫治疗敏感。
Cancer Discov. 2023 Jun 2;13(6):1454-1477. doi: 10.1158/2159-8290.CD-22-0907.
6
FGFR1/MAPK-directed brachyury activation drives PD-L1-mediated immune evasion to promote lung cancer progression.FGFR1/MAPK 靶向的 brachyury 激活驱动 PD-L1 介导的免疫逃逸,促进肺癌进展。
Cancer Lett. 2022 Oct 28;547:215867. doi: 10.1016/j.canlet.2022.215867. Epub 2022 Aug 17.
7
The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020.2020年食管鳞状细胞癌和食管腺癌发病率及死亡率的全球格局以及至2040年的预测:来自GLOBOCAN 2020的新估计
Gastroenterology. 2022 Sep;163(3):649-658.e2. doi: 10.1053/j.gastro.2022.05.054. Epub 2022 Jun 4.
8
Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression.脂多糖通过对长链非编码RNA MIR155HG进行m6A修饰以上调PD-L1表达,从而促进肝癌细胞的免疫逃逸。
Cell Biol Toxicol. 2022 Dec;38(6):1159-1173. doi: 10.1007/s10565-022-09718-0. Epub 2022 Apr 19.
9
Efficacy and activity of PD-1 blockade in patients with advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis with focus on the value of PD-L1 combined positive score.PD-1 阻断在晚期食管鳞癌患者中的疗效和活性:一项系统评价和荟萃分析,重点关注 PD-L1 联合阳性评分的价值。
ESMO Open. 2022 Feb;7(1):100380. doi: 10.1016/j.esmoop.2021.100380. Epub 2022 Jan 27.
10
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells.PD-L1 CAR 效应细胞诱导针对靶细胞的自我放大细胞毒性效应。
J Immunother Cancer. 2022 Jan;10(1). doi: 10.1136/jitc-2021-002500.